James T. Cassidy

9.9k total citations · 3 hit papers
106 papers, 7.2k citations indexed

About

James T. Cassidy is a scholar working on Hematology, Oncology and Rheumatology. According to data from OpenAlex, James T. Cassidy has authored 106 papers receiving a total of 7.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Hematology, 30 papers in Oncology and 21 papers in Rheumatology. Recurrent topics in James T. Cassidy's work include Autoimmune and Inflammatory Disorders Research (25 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Colorectal Cancer Treatments and Studies (17 papers). James T. Cassidy is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (25 papers), Immunodeficiency and Autoimmune Disorders (18 papers) and Colorectal Cancer Treatments and Studies (17 papers). James T. Cassidy collaborates with scholars based in United States, United Kingdom and Spain. James T. Cassidy's co-authors include Howard L. McLeod, Donita B. Sullivan, Weiguang Wang, Ross E. Petty, George W. Jourdian, Saul Roseman, Laura S. Hillman, Fernando Rivera, Josep Tabernero and Susanna B. Park and has published in prestigious journals such as Science, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

James T. Cassidy

104 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study

2010 1.4k citations Jean‐Yves Douillard, Salvatore Siena et al. Journal of Clinical Oncology profile →
Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API

2006 603 citations Daniel P. McNamara, S.L. Childs et al. Pharmaceutical Research profile →
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis

2013 558 citations James T. Cassidy et al. profile →

Peers

James T. Cassidy

ONCOL

PRM

HEMAT

RHEUM

Frank M. Balis United States

Jan H. Schornagel Netherlands

Sten Eriksson Sweden

David Murray United States

G. Stoter Netherlands

Merrill J. Egorin United States

Giuseppe Toffoli Italy

Peter C. Adamson United States

Dirk Th. Sleijfer Netherlands

Martin H. Cohen United States

Frank M. Balis United States

James T. Cassidy

3.8k ×1.3

ONCOL

3.6k ×2.3

2.4k ×2.0

PRM

1.2k ×1.0

HEMAT

428 ×0.5

RHEUM

Citations per year, relative to James T. Cassidy James T. Cassidy (= 1×) peers Frank M. Balis

Countries citing papers authored by James T. Cassidy

Since Specialization

Citations

This map shows the geographic impact of James T. Cassidy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James T. Cassidy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James T. Cassidy more than expected).

Fields of papers citing papers by James T. Cassidy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James T. Cassidy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James T. Cassidy. The network helps show where James T. Cassidy may publish in the future.

Co-authorship network of co-authors of James T. Cassidy

This figure shows the co-authorship network connecting the top 25 collaborators of James T. Cassidy. A scholar is included among the top collaborators of James T. Cassidy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James T. Cassidy. James T. Cassidy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tabernero, Josep, Rocio García‐Carbonero, James T. Cassidy, et al.. (2013). Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial. Clinical Cancer Research. 19(9). 2541–2550. 69 indexed citations

Cheung, Winson Y., Qian Shi, Michael J. O’Connell, et al.. (2013). The Predictive and Prognostic Value of Sex in Early-Stage Colon Cancer: A Pooled Analysis of 33,345 Patients from the ACCENT Database. Clinical Colorectal Cancer. 12(3). 179–187. 28 indexed citations

Douillard, Jean‐Yves, Salvatore Siena, James T. Cassidy, et al.. (2010). Randomized, Phase III Trial of Panitumumab With Infusional Fluorouracil, Leucovorin, and Oxaliplatin (FOLFOX4) Versus FOLFOX4 Alone As First-Line Treatment in Patients With Previously Untreated Metastatic Colorectal Cancer: The PRIME Study. Journal of Clinical Oncology. 28(31). 4697–4705. 1351 indexed citations breakdown →

Siena, Salvatore, Jean‐Yves Douillard, James T. Cassidy, et al.. (2010). Prime study : a randomised phase 3 study of panitumumab with Folfox4 versus Folfox4 alone as first line treatment for metastatic colorectal cancer (mCRC). Annals of Oncology. 21. 1 indexed citations

Hillman, Laura S., et al.. (2008). Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: Effect of supplementation with vitamin D and calcium. Pediatric Pulmonology. 43(8). 772–780. 27 indexed citations

Hillman, Laura S., et al.. (2008). Percent true calcium absorption, mineral metabolism, and bone mass in children with arthritis: Effect of supplementation with vitamin D₃ and calcium. Arthritis & Rheumatism. 58(10). 3255–3263. 17 indexed citations

Cassidy, James T., Jane D. Kivlin, Carol B. Lindsley, & James J. Nocton. (2006). Exploraciones oftalmológicas en los niños con artritis reumatoide juvenil. PEDIATRICS. 61(5). 344–346. 1 indexed citations

McNamara, Daniel P., S.L. Childs, Jennifer Giordano, et al.. (2006). Use of a Glutaric Acid Cocrystal to Improve Oral Bioavailability of a Low Solubility API. Pharmaceutical Research. 23(8). 1888–1897. 603 indexed citations breakdown →

Wang, Weiguang, James T. Cassidy, Vincent O’Brien, Kevin M. Ryan, & Elaina Collie–Duguid. (2004). Mechanistic and Predictive Profiling of 5-Fluorouracil Resistance in Human Cancer Cells. Cancer Research. 64(22). 8167–8176. 95 indexed citations

10.

Gourley, Charlie, James T. Cassidy, Leslie Samuel, et al.. (2004). A phase I study of the trinuclear platinum compound, BBR�3464, in combination with protracted venous infusional 5-fluorouracil in patients with advanced cancer. Cancer Chemotherapy and Pharmacology. 53(2). 95–101. 19 indexed citations

11.

Curran, Stephanie, et al.. (2002). Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases. Human Pathology. 33(11). 1114–1119. 35 indexed citations

12.

Collie–Duguid, Elaina, Stephen J. Johnston, A.J. Cowieson, et al.. (2001). Thymidine phosphorylase and dihydropyrimidine dehydrogenase protein expression in colorectal cancer. International Journal of Cancer. 94(2). 297–301. 20 indexed citations

13.

McLeod, Howard L., et al.. (1997). Comparison of 5‐Fluorouracil Pharmacokinetics in Whole Blood, Plasma, and Red Blood Cells in Patients with Colorectal Cancer. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 17(5). 881–886. 17 indexed citations

14.

Cassidy, James T. & Balu H. Athreya. (1997). Pediatric rheumatology: Status of the subspecialty in united states medical schools. Arthritis & Rheumatism. 40(6). 1182–1182. 18 indexed citations

15.

Cassidy, James T., et al.. (1993). Methotrexate in Juvenile Rheumatoid Arthritis. Drug Safety. 9(5). 325–339. 36 indexed citations

16.

Giannini, Edward H., Earl J. Brewer, N. N. Kuzmina, et al.. (1992). Methotrexate in Resistant Juvenile Rheumatoid Arthritis. New England Journal of Medicine. 326(16). 1043–1049. 405 indexed citations

17.

Cassidy, James T., et al.. (1989). Herpes simplex virus,Candida albicans and mouth ulcers in neutropenic patients with non-haematological malignancy. Cancer Chemotherapy and Pharmacology. 25(1). 75–76. 10 indexed citations

18.

Gouyette, Alain, et al.. (1988). Flavone acetic acid: a nonlinear pharmacokinetic model. Cancer Chemotherapy and Pharmacology. 22(2). 114–9. 12 indexed citations

19.

Petty, Ross E., James T. Cassidy, & Donita B. Sullivan. (1973). Clinical correlates of antinuclear antibodies in juvenile rheumatoid arthritis. The Journal of Pediatrics. 83(3). 386–389. 56 indexed citations

20.

Cassidy, James T., Gerald L. Brody, & William Martel. (1967). Monarticular juvenile rheumatoid arthritis. The Journal of Pediatrics. 70(6). 867–875. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact